about
2-Oleoyl glycerol is a GPR119 agonist and signals GLP-1 release in humansHead-to-head comparison of intensive lifestyle intervention (U-TURN) versus conventional multifactorial care in patients with type 2 diabetes: protocol and rationale for an assessor-blinded, parallel group and randomised trialTreatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists.Effect of an Intensive Lifestyle Intervention on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial.Reduced glucose tolerance and insulin resistance induced by steroid treatment, relative physical inactivity, and high-calorie diet impairs the incretin effect in healthy subjects.Comparing olive oil and C4-dietary oil, a prodrug for the GPR119 agonist, 2-oleoyl glycerol, less energy intake of the latter is needed to stimulate incretin hormone secretion in overweight subjects with type 2 diabetes.Electroretinography in healthy subjects in relation to systemic glucocorticoid intake.Increased postprandial GIP and glucagon responses, but unaltered GLP-1 response after intervention with steroid hormone, relative physical inactivity, and high-calorie diet in healthy subjects.Why prescribe exercise as therapy in type 2 diabetes? We have a pill for that!Gastric emptying of orally administered glucose solutions and incretin hormone responses are unaffected by laparoscopic adjustable gastric banding.Impaired incretin-induced amplification of insulin secretion after glucose homeostatic dysregulation in healthy subjects.First case report associating chronic pancreatitis and Ehlers-Danlos syndrome
P50
Q28243838-B9BF9A5E-AB25-4C9D-A208-6C519C227C4BQ36374152-0F69A125-7CF2-44DC-9A6F-34DC97808F30Q37558705-0752B4DC-05A2-4A84-A2A4-4BBF57DA73B1Q38372172-BAE902D2-BB58-4CC4-A14D-C129826B3F4AQ43089866-1D0F5753-4CA4-4090-989C-B30FF4AD2D7EQ48043236-76A3CCBE-1F04-4251-9E94-6D10EBE1A924Q51363488-59AEC71E-4CFC-4868-A0C0-0DA7F4A488B8Q51387579-4628CC98-7E7F-4138-94B7-2A0A0CA9289BQ52682035-2ABF1FC4-B83C-4BB6-97EE-8BBCA12CF3FCQ53080088-C29EAA39-ED42-41F4-B010-DD345FF364F0Q53667369-FCB18A18-BB5C-49BF-9EBD-49C1A84A2D56Q82900531-6D94246B-1E7C-4C10-BD25-F8EB3D402249
P50
description
researcher ORCID ID = 0000-0002-2587-5589
@en
wetenschapper
@nl
name
Katrine B Hansen
@ast
Katrine B Hansen
@en
Katrine B Hansen
@nl
type
label
Katrine B Hansen
@ast
Katrine B Hansen
@en
Katrine B Hansen
@nl
prefLabel
Katrine B Hansen
@ast
Katrine B Hansen
@en
Katrine B Hansen
@nl
P21
P31
P496
0000-0002-2587-5589